Free tool
FAERS Monitor: Genotropin Preservative Free
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 020280 or its brand name (Genotropin Preservative Free, Somatropin). Reports on generic versions are filed under their own applications.
Reports
53,357
Serious
11,105
21% of reports
Hospitalization
4,263
Death reported
900
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug dose omission by device18,613
- device leakage9,818
- device breakage8,090
- device mechanical issue7,703
- device information output issue7,074
- device issue5,025
- wrong technique in device usage process4,667
- device use error3,272
- poor quality device used3,103
- device physical property issue2,983
- device use issue2,625
- device delivery system issue2,349
- device defective2,119
- device malfunction2,014
- incorrect dose administered by device1,744
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 220 |
| 2005 | 196 |
| 2006 | 224 |
| 2007 | 246 |
| 2008 | 187 |
| 2009 | 317 |
| 2010 | 563 |
| 2011 | 493 |
| 2012 | 1,581 |
| 2013 | 489 |
| 2014 | 557 |
| 2015 | 733 |
| 2016 | 921 |
| 2017 | 1,186 |
| 2018 | 1,911 |
| 2019 | 1,657 |
| 2020 | 1,894 |
| 2021 | 3,374 |
| 2022 | 5,194 |
| 2023 | 8,591 |
| 2024 | 9,365 |
| 2025 | 8,370 |
| 2026 | 5,088 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,802 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| device information output issueSignal | 7,074 | 3867.0 | 3583.3 | 2,526,322 |
| device mechanical issueSignal | 7,703 | 503.5 | 487.4 | 1,695,834 |
| device physical property issueSignal | 2,983 | 250.6 | 239.5 | 453,054 |
| poor quality device usedSignal | 3,103 | 176.0 | 168.8 | 373,131 |
| drug dose omission by deviceSignal | 18,613 | 122.6 | 120.8 | 1,717,611 |
| device leakageSignal | 9,818 | 115.1 | 112.7 | 860,697 |
| device breakageSignal | 8,090 | 97.8 | 95.6 | 622,160 |
| device use issueSignal | 2,625 | 69.4 | 66.6 | 150,515 |
| device defectiveSignal | 2,119 | 54.8 | 52.4 | 98,208 |
| wrong technique in device usage processSignal | 4,667 | 43.6 | 42.4 | 175,396 |
| device use errorSignal | 3,272 | 40.9 | 39.5 | 115,443 |
| device delivery system issueSignal | 2,349 | 36.9 | 35.4 | 75,071 |
| incorrect dose administered by deviceSignal | 1,744 | 28.0 | 26.7 | 42,457 |
| device issueSignal | 5,025 | 23.3 | 22.7 | 101,834 |
| device malfunctionSignal | 2,014 | 11.6 | 11.1 | 19,005 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.